Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayral

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|December 23, 2009
Design and synthesis of novel diaminoquinazolines with in vivo efficacy for beta-catenin/T-cell transcriptional factor 4 pathway inhibitionChristoph M Dehnhardt, Aranapakam M Venkatesan, Zecheng Chen, et al.
Cancer Research|July 9, 2009
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycinKer Yu, Lourdes Toral-Barza, Celine Shi, et al.
Journal of Medicinal Chemistry|September 3, 2004
Synthesis and biological activity of analogues of the antimicrotubule agent N,beta,beta-trimethyl-L-phenylalanyl-N(1)-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N(1),3-dimethyl-L-valinamide (HTI-286)Arie Zask, Gary Birnberg, Katherine Cheung, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2009
Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitorsAranapakam M Venkatesan, Christoph M Dehnhardt, Zecheng Chen, et al.
Journal of Medicinal Chemistry|August 4, 2009
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidinesArie Zask, Jeroen C Verheijen, Kevin Curran, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 19, 2025
Free water predicts dementia with Lewy bodies in isolated REM sleep behavior disorderCeline Haddad, Véronique Daneault, Violette Ayral, et al.
Cancer Research|January 14, 2010
Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2Ker Yu, Celine Shi, Lourdes Toral-Barza, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 12, 2025
Altered network efficiency in isolated REM sleep behavior disorder: A multicentric studyChristina Tremblay, Alexandre Pastor-Bernier, François Rheault, et al.
Clinical and Experimental Rheumatology|September 29, 2015
Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER networkH Che, A Etcheto, E Dernis, et al.
Scientific Reports|August 27, 2016
Variations in Multiple Syndromic Deafness Genes Mimic Non-syndromic Hearing LossG Bademci, F B Cengiz, J Foster Ii, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|December 23, 2009
Design and synthesis of novel diaminoquinazolines with in vivo efficacy for beta-catenin/T-cell transcriptional factor 4 pathway inhibitionChristoph M Dehnhardt, Aranapakam M Venkatesan, Zecheng Chen, et al.
Cancer Research|July 9, 2009
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycinKer Yu, Lourdes Toral-Barza, Celine Shi, et al.
Journal of Medicinal Chemistry|September 3, 2004
Synthesis and biological activity of analogues of the antimicrotubule agent N,beta,beta-trimethyl-L-phenylalanyl-N(1)-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N(1),3-dimethyl-L-valinamide (HTI-286)Arie Zask, Gary Birnberg, Katherine Cheung, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2009
Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitorsAranapakam M Venkatesan, Christoph M Dehnhardt, Zecheng Chen, et al.
Journal of Medicinal Chemistry|August 4, 2009
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidinesArie Zask, Jeroen C Verheijen, Kevin Curran, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 19, 2025
Free water predicts dementia with Lewy bodies in isolated REM sleep behavior disorderCeline Haddad, Véronique Daneault, Violette Ayral, et al.
Cancer Research|January 14, 2010
Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2Ker Yu, Celine Shi, Lourdes Toral-Barza, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 12, 2025
Altered network efficiency in isolated REM sleep behavior disorder: A multicentric studyChristina Tremblay, Alexandre Pastor-Bernier, François Rheault, et al.
Clinical and Experimental Rheumatology|September 29, 2015
Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER networkH Che, A Etcheto, E Dernis, et al.
Scientific Reports|August 27, 2016
Variations in Multiple Syndromic Deafness Genes Mimic Non-syndromic Hearing LossG Bademci, F B Cengiz, J Foster Ii, et al.
Pageof 22